bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.15.648961

Identification and characterization of the surface layer protein AvsA in outer membrane vesicles, antibiotic resistance, and in vivo host colonization in Aeromonas veronii

Abstract

Outer membrane vesicles (OMVs) are important in bacterial communication and the transfer of virulence factors. In this study, we identified and characterized the surface layer protein (SLP) AvsA (Aeromonas veronii surface protein A) in the OMVs of Aeromonas veronii Hm21, a strain isolated from the medicinal leech Hirudo verbana. The surface layer proteins (SLPs) play critical roles in how bacteria interact with each other and their environments, particularly in mediating antibiotic resistance and facilitating host colonization. Furthermore, we investigate the ability of AvsA to confer protection against antibiotics, affect biofilm formation, and contribute to host colonization, providing insight into antibiotic resistance and two crucial factors contributing to the persistence of the bacteria in its host. Our findings suggest that AvsA enhances antibiotic tolerance, facilitates biofilm development, and is important for successful colonization of the leech digestive tract. These data demonstrate that AvsA performs important roles in a wide range of critical phenotypes. This work provides insights into the functional significance of SLPs in A. veronii and highlights AvsA as a potential target for modulating bacterial colonization and resilience against antibiotics. ImportanceOuter membrane vesicles (OMVs) are important for bacterial communication, pathogenesis, and stress adaptation, yet how this is accomplished remains poorly understood. Here, we identify and characterize a surface layer protein (SLP), AvsA, associated with OMVs in Aeromonas veronii Hm21. Bioinformatic, phylogenetic, and mass spectrometry analyses suggest that Aeromonas veronii ORF M001_06550 encodes a surface layer protein (SLP) with high similarity to a characterized A. hydrophila SLP, supporting its designation as Aeromonas veronii Surface Protein A (AvsA). AvsA forms a paracrystalline layer on bacterial cells and OMVs. Functionally, AvsA contributes to antibiotic resistance, enhances biofilm formation, and is essential for colonization in a symbiotic host, the medicinal leech. These findings highlight a novel role of SLPs in bacterial physiology and host interactions. Given the widespread presence of AvsA homologs, our study provides insights into conserved bacterial mechanisms that may be relevant for both pathogenic and beneficial host-microbe interactions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vieira Da Silva, C., Arsenault, D., Kramer-Earley, R., Robinson, V. L., Milligan-McClellan, K. C., Graf, J.. 2025-04-15. Identification and characterization of the surface layer protein AvsA in outer membrane vesicles, antibiotic resistance, and in vivo host colonization in Aeromonas veronii. https://doi.org/10.1101/2025.04.15.648961

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗